Skye Bioscience, Inc.

SEC 8-K · Filed

0001628280-26-023699Accepted

Applies to the EDGAR acceptance time.

Other time zone
Leadership changesItem 5.02

John P. Sharp — appointed as Chief Financial Officer

appointed John P. Sharp as the Chief Financial Officer
Structured facts
{
  "action": "appointed",
  "evidence": "appointed John P. Sharp as the Chief Financial Officer",
  "person": "John P. Sharp",
  "role": "Chief Financial Officer"
}